MBOT - Microbot Medical Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Microbot Medical Inc.

25 Recreation Park Drive
Unit 108
Hingham, MA 02043
United States
781-875-3605
http://www.microbotmedical.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees9

Key Executives

NameTitlePayExercisedYear Born
Mr. Harel GadotCo-Founder, Pres, CEO & Chairman428.8kN/A1973
Mr. David Ben Naim CPA, M.B.A.Chief Financial Officer70.03kN/A1969
Dr. Simon SharonCTO & Chairman of Scientific Advisory BoardN/AN/AN/A
Prof. Moshe ShohamCo-Founder, Scientific Director & Member of Scientific Advisory BoardN/AN/A1952
Dr. Eric C. LeuthardtScientific Director & Member of Scientific Advisory BoardN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and CardioSert micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; transformational self-propelled and semi-disposable locomotive device to treat capabilities within tubular lumens in the human body, such as the colon, blood vessels, and the urinary tract; and a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery. As of April 23, 2019, it had 32 issued/allowed patents and 19 patent applications pending worldwide Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Corporate Governance

Microbot Medical Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.